Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem?

scientific article

Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/344447
P698PubMed publication ID12471591

P50authorBart J. CurrieQ63244903
P2093author name stringDragana Drinkovic
Alison Wesley
David James Holland
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectcystic fibrosisQ178194
Burkholderia pseudomalleiQ140475
P304page(s)e138-40
P577publication date2002-11-19
P1433published inClinical Infectious DiseasesQ5133764
P1476titleCystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem?
P478volume35

Reverse relations

cites work (P2860)
Q35802333An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis
Q42286592Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples.
Q41390712Burkholderia pseudomallei in cystic fibrosis and treatment complications
Q37185458Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report
Q35535652Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis
Q34491552Clinical significance of microbial infection and adaptation in cystic fibrosis
Q92769947Comparative genomics confirms a rare melioidosis human-to-human transmission event and reveals incorrect phylogenomic reconstruction due to polyclonality
Q36314557Cystic fibrosis patient with Burkholderia pseudomallei infection acquired in Brazil
Q36895659Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection
Q35407877Efflux pump-mediated drug resistance in Burkholderia.
Q91677376Genetic variation associated with infection and the environment in the accidental pathogen Burkholderia pseudomallei
Q36934706Infections in chronic lung diseases
Q35219793Intravenous therapy duration and outcomes in melioidosis: a new treatment paradigm
Q28245689Management of melioidosis
Q56286799Melioidosis
Q43126480Melioidosis diagnostic workshop, 2013.
Q28083880Melioidosis in Travelers: Review of the Literature
Q33663333Melioidosis: Clinical impact and public health threat in the tropics.
Q37874027Melioidosis: a clinical overview
Q24522461Melioidosis: epidemiology, pathophysiology, and management
Q34436824Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell Matrix-assisted Laser Desorption/Ionisation mass spectrometric typing
Q37373050Recent advances in the microbiology of respiratory tract infection in cystic fibrosis
Q58763258Relapse of chronic melioidosis in a paediatric cystic fibrosis patient: first case report from Malaysia
Q33769912The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study
Q89495385Transcriptomic analysis of longitudinal Burkholderia pseudomallei infecting the cystic fibrosis lung
Q37789930Travelling with cystic fibrosis: Recommendations for patients and care team members
Q33555304Within-Host Evolution of Burkholderia pseudomallei during Chronic Infection of Seven Australasian Cystic Fibrosis Patients

Search more.